Amount Raised
$6 Million
Round Type
Funding Round
New YorkHealthcareInvestors
Description
On December 22, 2025, Indaptus Therapeutics, Inc. completed a funding round through a Securities Purchase Agreement with David E. Lazar. The agreement involved the purchase of a total of 1,000,000 shares of convertible preferred stock at a price of $6.00 per share
Who else raised in Healthcare around the same time
Companies in the same sectors as Indaptus Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Meduloc raised $2.2M (Seed) on February 6, 2026.
- KoKo Medical raised $8M on February 6, 2026.
- Dentologie Enterprises raised $5.6M on February 5, 2026.
- SonoVascular raised $6M (Series A) on February 4, 2026.
- PAVmed raised $45M (Series D) on February 4, 2026.
- Corus Orthodontists raised $16M on February 2, 2026.
Who to call at Indaptus Therapeutics, Inc., and when
A new round usually means Indaptus Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Indaptus Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Indaptus Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Indaptus Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Indaptus Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Indaptus Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.